Streetbeat News

Price Targets

LOW

B of A Securities analyst Elizabeth Suzuki maintains a Buy rating on Lowe's Companies and raises the price target from $275 to $305.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:21 pm

ALNY

Cantor Fitzgerald analyst Olivia Brayer has reiterated a Neutral rating for Alnylam Pharmaceuticals, maintaining a price target of $220.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:12 pm

SYM

Cantor Fitzgerald analyst Derek Soderberg has reiterated an Overweight rating on Symbotic (NASDAQ:SYM) and maintained a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:10 pm

AMD

Roth MKM analyst Suji Desilva has reiterated a Buy rating on Advanced Micro Devices (AMD) and maintained a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:10 pm

CTGO

Roth MKM analyst Mike Niehuser has maintained a Buy rating on Contango Ore (AMEX:CTGO) and raised the price target from $33 to $37.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:07 pm

TSLA

Cantor Fitzgerald analyst Andres Sheppard has reiterated a Neutral rating on Tesla (NASDAQ:TSLA) and maintained a price target of $245.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:07 pm

TSLA

Roth MKM analyst Craig Irwin has reiterated a Neutral rating on Tesla (NASDAQ:TSLA) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:03 pm

NRIX

In the past three months, 6 analysts have rated Nurix Therapeutics (NASDAQ:NRIX) with varying perspectives. The average 12-month price target has increased by 28.82% to $33.17. Analysts have shown a positive shift in sentiment, with recent upgrades and increased price targets.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 5:03 pm

VAL

Valaris (NYSE:VAL) has received mixed analyst ratings over the past quarter, with a decrease in the average 12-month price target from $86.25 to $75.0. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Valaris has shown strong financial performance with significant revenue growth and profitability metrics surpassing industry standards.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 5:02 pm

MOS

Mosaic (NYSE:MOS) has been analyzed by 7 analysts, showing a range of sentiments from bullish to bearish. Recent ratings indicate a shift towards a more neutral stance, with a decrease in the average 12-month price target from $32.00 to $29.43. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Mosaic's financials show a decline in revenue growth and challenges in ROE, but strong net margin and ROA. The company's debt management is sound with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 5:02 pm